Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
miR-1285-3p Controls Colorectal Cancer Proliferation and Escape from Apoptosis through DAPK2.
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
- معلومة اضافية
- المصدر:
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
- بيانات النشر:
Original Publication: Basel, Switzerland : MDPI, [2000-
- الموضوع:
- نبذة مختصرة :
MicroRNAs are tiny but powerful regulators of gene expression at the post-transcriptional level. Aberrant expression of oncogenic and tumor-suppressor microRNAs has been recognized as a common feature of human cancers. Colorectal cancer represents a major clinical challenge in the developed world and the design of innovative therapeutic approaches relies on the identification of novel biological targets. Here, we perform a functional screening in colorectal cancer cells using a library of locked nucleic acid (LNA)-modified anti-miRs in order to unveil putative oncogenic microRNAs whose inhibition yields a cytotoxic effect. We identify miR-1285-3p and further explore the effect of its targeting in both commercial cell lines and primary colorectal cancer stem cells, finding induction of cell cycle arrest and apoptosis. We show that DAPK2, a known tumor-suppressor, is a novel miR-1285 target and mediates both the anti-proliferative and the pro-apoptotic effects of miR-1285 depletion. Altogether, our findings uncover a novel oncogenic microRNA in colorectal cancer and lay the foundation for further studies aiming at the development of possible therapeutic strategies based on miR-1285 targeting.
Competing Interests: Supplementary Materials: The following are available online at www.mdpi.com/1422-0067/21/7/2423/s1.
- References:
Oncogene. 2011 Mar 24;30(12):1481-8. (PMID: 21102518)
Cell Death Differ. 2014 May;21(5):774-82. (PMID: 24488097)
Mol Cell Biol. 2015 Oct 19;36(1):132-43. (PMID: 26483415)
Mol Cell Biol. 2000 Feb;20(3):1044-54. (PMID: 10629061)
Cancer Cell. 2014 Apr 14;25(4):469-83. (PMID: 24735923)
Nat Commun. 2018 May 1;9(1):1759. (PMID: 29717115)
Autophagy. 2016 Dec;12(12):2271-2285. (PMID: 27653365)
N Engl J Med. 2013 May 2;368(18):1685-94. (PMID: 23534542)
Apoptosis. 2014 Feb;19(2):286-97. (PMID: 24220854)
J Biol Chem. 2009 Jan 23;284(4):2012-22. (PMID: 18957423)
Curr Opin Pharmacol. 2017 Aug;35:1-11. (PMID: 28527911)
Cell. 2011 Mar 4;144(5):646-74. (PMID: 21376230)
N Engl J Med. 2008 Oct 23;359(17):1757-65. (PMID: 18946061)
Int J Mol Sci. 2017 Mar 15;18(3):. (PMID: 28294974)
Nucleic Acids Res. 2017 Sep 29;45(17):10206-10217. (PMID: 28973454)
Cell Stem Cell. 2014 Dec 4;15(6):692-705. (PMID: 25479747)
Int J Mol Sci. 2018 Mar 23;19(4):. (PMID: 29570632)
Nat Rev Drug Discov. 2017 Mar;16(3):203-222. (PMID: 28209991)
Oncotarget. 2016 May 3;7(18):26516-34. (PMID: 27049921)
Cancer Biomark. 2019;25(1):1-10. (PMID: 31006663)
Nature. 2007 Jan 4;445(7123):111-5. (PMID: 17122771)
Oncogene. 2016 Mar 3;35(9):1134-42. (PMID: 25982274)
Cell Death Dis. 2018 Jan 19;9(2):49. (PMID: 29352138)
Cell Rep. 2014 Aug 7;8(3):909-21. (PMID: 25066129)
Oncogene. 2008 Sep 25;27(43):5706-16. (PMID: 18521079)
Biochem Biophys Res Commun. 2015 Dec 4-11;468(1-2):113-8. (PMID: 26529546)
Oncogene. 1999 Jun 10;18(23):3471-80. (PMID: 10376525)
J Leukoc Biol. 2007 Jun;81(6):1599-608. (PMID: 17347302)
Cell Death Differ. 2015 Mar;22(3):465-75. (PMID: 25361081)
EMBO J. 2001 Mar 1;20(5):1099-113. (PMID: 11230133)
Nat Genet. 2003 Jul;34(3):267-73. (PMID: 12808457)
Adv Nutr. 2016 Mar 15;7(2):418-9. (PMID: 26980827)
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50. (PMID: 16199517)
Clin Cancer Res. 2013 Apr 15;19(8):2096-106. (PMID: 23446999)
Nature. 2005 Jun 9;435(7043):834-8. (PMID: 15944708)
J Clin Invest. 2016 Dec 1;126(12):4585-4602. (PMID: 27820701)
Tumour Biol. 2015 Jan;36(1):219-25. (PMID: 25230788)
Science. 2010 Jan 8;327(5962):198-201. (PMID: 19965718)
Cell Death Dis. 2017 Jul 13;8(7):e2929. (PMID: 28703801)
Nature. 2004 Sep 16;431(7006):350-5. (PMID: 15372042)
Cell. 2000 Jan 7;100(1):57-70. (PMID: 10647931)
Dis Model Mech. 2017 Mar 1;10(3):197-214. (PMID: 28250048)
J Leukoc Biol. 2014 Jan;95(1):83-93. (PMID: 24038216)
- Grant Information:
Investigator Grant 13431 Associazione Italiana per la Ricerca sul Cancro
- Contributed Indexing:
Keywords: DAPK2; LNAs; apoptosis; cancer stem cells; cell cycle; colorectal cancer; microRNAs
- الرقم المعرف:
0 (Antineoplastic Agents)
0 (MIRN1285 microRNA, human)
0 (MicroRNAs)
0 (Oligonucleotides)
0 (locked nucleic acid)
EC 2.7.11.1 (DAPK2 protein, human)
EC 2.7.11.1 (Death-Associated Protein Kinases)
- الموضوع:
Date Created: 20200405 Date Completed: 20210107 Latest Revision: 20210107
- الموضوع:
20240628
- الرقم المعرف:
PMC7177834
- الرقم المعرف:
10.3390/ijms21072423
- الرقم المعرف:
32244500
No Comments.